XM no presta servicios a los residentes de Estados Unidos de América.

XM no presta servicios a los residentes de Estados Unidos de América.
S
S

Sage

Noticias

Reuters - Hace 4 días

U.S. Boston Beer Company, Inter Parfums, Netflix

U.S. RESEARCH ROUNDUP-Boston Beer Company, Inter Parfums, Netflix July 12 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Boston Beer Company, Inter Parfums and Netflix, on Friday. HIGHLIGHTS * Boston Beer Company Inc SAM.N : Piper Sandler cuts PT to $344 from $350 * Inter Parfums Inc IPAR.O : Jefferies raises to buy from hold * Netflix Inc NFLX.O : JP Morgan raises target price to $750 from $650 * Smurfit Westrock SW
C
N
N
P
S
D
E
C
C
E
M
Reuters - Hace 6 días

U.S. Nvidia, Qualcomm, Tesla

U.S. RESEARCH ROUNDUP-Nvidia, Qualcomm, Tesla July 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Nvidia, Qualcomm and Tesla, on Wednesday. HIGHLIGHTS * Brighthouse Financial Inc BHF.O : Jefferies raises to buy from hold * Legalzoom.Com Inc LZ.O : JP Morgan cuts to neutral from overweight * Nvidia Corp NVDA.O : KeyBanc raises target price to $180 * Qualcomm Inc QCOM.O : KeyBanc raises target price to $225 * Tesla
A
A
A
A
A
C
G
M
M
N
P
Q
S
T
A
A
A
C
O
B
T
A
A
A
A
C
G
L
U
Reuters - Hace 4 semanas

U.S. Citigroup, Nike, Tesla

U.S. RESEARCH ROUNDUP-Citigroup, Nike, Tesla June 20 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Citigroup, Nike and Tesla, on Thursday. HIGHLIGHTS * Bread Financial Holdings Inc BFH.N : Evercore ISI raises to in line from underperform * Citigroup C.N : KBW raises target price to $69 from $66 * Lennar Corp LEN.N : Evercore ISI cuts target price to $237 from $238 * Nike Inc NKE.N : Barclays cuts target price to $1
C
I
M
N
N
S
T
D
F
P
A
A
Reuters - Hace 1 mes

U.S. STOCKS Affirm, Calavo Growers, Shoals Technologies

BUZZ-U.S. STOCKS ON THE MOVE-Affirm, Calavo Growers, Shoals Technologies Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes slipped on Tuesday as investors turned cautious ahead of a crucial inflation reading and a policy announcement from the Federal Reserve expected this week, although a recovery in Apple's shares helped curtail losses.
A
G
G
J
N
S
R
U
U
S
S
R
Reuters - Hace 1 mes

U.S. STOCKS Spotify, Affirm, Calavo Growers

BUZZ-U.S. STOCKS ON THE MOVE-Spotify, Affirm, Calavo Growers Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes declined on Tuesday as caution dampened investor enthusiasm ahead of a crucial inflation reading and a policy announcement from the Federal Reserve expected this week.
A
A
G
J
N
S
R
U
U
S
S
F
R
Reuters - Hace 1 mes

U.S. STOCKS Sage, General Motors, Viridian

BUZZ-U.S. STOCKS ON THE MOVE-Sage, General Motors, Viridian Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street was set to open lower on Tuesday, with futures tracking all three major indexes in the red as investors were cautious ahead of crucial inflation data and a policy announcement from the Federal Reserve expected this week.
N
S
R
U
S
R
Reuters - Hace 1 mes

Futures ease on rate-cut jitters ahead of inflation data, Fed meet

US STOCKS-Futures ease on rate-cut jitters ahead of inflation data, Fed meet For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window. Eli Lilly up as Alzheimer's drug gets US FDA panel backing Crypto stocks fall as bitcoin hits one-week low GM approves $6 billion share buyback plan Futures lower: Dow 0.31%, S&P 0.22%, Nasdaq 0.23% Updated at 8:16 a.m.
A
A
M
N
S
U
U
U
B
Reuters - Hace 1 mes

Sage climbs as Huntington's drug found to be safe in mid-stage study

BUZZ-Sage climbs as Huntington's drug found to be safe in mid-stage study ** Shares of Sage Therapeutics SAGE.O rise 1.8% to $11.10 premarket ** Drug developer says its drug, dalzanemdor, was found to be safe in patients with a rare, genetic neurological condition called Huntington's disease in a part of a mid-stage study ** SAGE says the study in
S
Reuters - Hace 1 mes

Futures slip as investors await Fed meeting, CPI numbers

US STOCKS-Futures slip as investors await Fed meeting, CPI numbers For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window. Eli Lilly up as Alzheimer's drug gets US FDA panel backing Crypto stocks fall as bitcoin hits one-week low Futures off: Dow 0.44%, S&P 0.33%, Nasdaq 0.33% Updated at 7:06 a.m.
A
N
S
U
U
U
B
Reuters - Hace 1 mes

Sage Therapeutics says rare disease drug found to be safe in mid-stage study

UPDATE 2-Sage Therapeutics says rare disease drug found to be safe in mid-stage study Updates shares in paragraph 4, adds details on trial in paragraphs 5 & 9, analysts comments in paragraphs 6, 8 & 10 June 11 (Reuters) - Sage Therapeutics SAGE.O said on Tuesday a part of a mid-stage study showed its experimental drug was safe and had some effect in patients with a rare, genetic neurological condition called Huntington's disease.
S
Reuters - Hace 1 mes

Sage Therapeutics' rare disease drug meets main goal in mid-stage study

Sage Therapeutics' rare disease drug meets main goal in mid-stage study June 11 (Reuters) - Sage Therapeutics SAGE.O said on Tuesday its experimental drug met the main goal of a mid-stage study in patients with a type of rare disease known as Huntington's disease. Reporting by Sriparna Roy in Bengaluru; Editing by Shailesh Kuber
S
Reuters - Hace 2 meses

U.S. Autodesk, McKesson, MicroStrategy

U.S. RESEARCH ROUNDUP-Autodesk, McKesson, MicroStrategy May 29 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Autodesk, McKesson and Microstrategy, on Wednesday. HIGHLIGHTS * Analog Devices Inc ADI.O : Raymond James raises target price to $260 from $215 * Autodesk Inc ADSK.O : Baird cuts target price to $289 from $296 * Cencora Inc COR.N : Baird raises target price to $280 from $277 * McKesson Corp MCK.N : Baird rai
A
C
S
A
A
U
D
M
L
M
Reuters - Hace 3 meses

SAGE Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

SAGE Therapeutics Inc reports results for the quarter ended in March - Earnings Summary SAGE Therapeutics Inc SAGE.OQ reported a quarterly adjusted loss of $1.80​​ per share for the quarter ended in March, higher than the same quarter last year, when the company reported EPS of $-2.46. The mean expectation of eighteen analysts for the quarter was for a loss of $1.65 per share.
S
Reuters - Hace 3 meses

U.S. STOCKS Globe Life, EQT, Ribbon Communications

BUZZ-U.S. STOCKS ON THE MOVE-Globe Life, EQT, Ribbon Communications Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes pared early gains to trade lower on Wednesday, as losses in heavyweight tech stocks outweighed positive earnings across several sectors and rising Treasury yields further pressured equities.
A
B
B
G
H
S
T
V
T
U
U
D
E
W
G
Reuters - Hace 3 meses

U.S. STOCKS MSCI, Globe Life, EQT Corp

BUZZ-U.S. STOCKS ON THE MOVE-MSCI, Globe Life, EQT Corp Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Nasdaq outpaced Wall Street peers on Wednesday, with Tesla leading gains among megacap stocks after its quarterly results, while upbeat earnings reports across other sectors also offered support.
A
B
B
G
H
S
T
V
T
U
U
E
W
F
G
Reuters - Hace 3 meses

Sage rises as partner Biogen posts strong Q1 sales of postpartum depression pill

BUZZ-Sage rises as partner Biogen posts strong Q1 sales of postpartum depression pill ** Shares of Sage Therapeutics SAGE.O up 13.1% at $14.65 premarket ** Partner Biogen BIIB.O reports $12 mln in Q1 revenue from post-partum depression pill Zurzuvae ** At least three analysts say that sales of Zurzuvae came in ahead of their expectations ** Jefferi
B
S
Reuters - Hace 3 meses

SAGE Therapeutics Inc <SAGE.OQ> expected to post a loss of $1.65 a share - Earnings Preview

SAGE Therapeutics Inc expected to post a loss of $1.65 a share - Earnings Preview SAGE Therapeutics Inc SAGE.OQ SAGE.O is expected to show a rise in quarterly revenue when it reports results on April 25 for the period ending March 31 2024 The Cambridge Massachusetts-based company is expected to report a 71.8% increase in revenue to $5.658 million from $3.29 million a year ago, according to the mean estimate from 17 analysts, based on LSEG data.
S
Reuters - Hace 3 meses

U.S. Builders Firstsource, Eli Lilly, Northern Trust

U.S. RESEARCH ROUNDUP- Builders Firstsource, Eli Lilly, Northern Trust April 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Builders Firstsource, Eli Lilly and Northern Trust, on Thursday. HIGHLIGHTS * Alphabet Inc GOOGL.O : Bernstein raises target price to $165 from $160 * Builders Firstsource Inc BLDR.N : Jefferies raises target price to $237 from $226 * Coinbase Global Inc COIN.O : Bernstein raises target price
A
A
C
C
C
C
F
G
J
N
Q
S
A
L
J
A
C
Reuters - Hace 3 meses

U.S. STOCKS Outset Medical, Interactive Brokers, US energy sector

BUZZ-U.S. STOCKS ON THE MOVE-Outset Medical, Interactive Brokers, US energy sector Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes fell in choppy trading on Wednesday with chip stocks among the top losers, while downbeat earnings reports from some industry majors, including insurer Travelers, added to the losses.
I
S
U
A
J
U
U
U
C
Reuters - Hace 3 meses

U.S. STOCKS Children's Place, Travelers, First Horizon

BUZZ-U.S. STOCKS ON THE MOVE-Children's Place, Travelers, First Horizon Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes rose on Wednesday, boosted by megacap growth stocks and as corporate results rolled in, while investors awaited commentary from Federal Reserve policymakers for clues on the economy's health.
A
I
S
U
A
A
J
U
U
U

Condiciones

Activos populares

Descargo de responsabilidades: Cada una de las entidades de XM Group proporciona un servicio de solo ejecución y acceso a nuestra plataforma de trading online, permitiendo a una persona ver o usar el contenido disponible en o a través del sitio web, sin intención de cambiarlo ni ampliarlo. Dicho acceso y uso están sujetos en todo momento a: (i) Términos y Condiciones; (ii) Advertencias de riesgo; y (iii) Descargo completo de responsabilidades. Por lo tanto, dicho contenido se proporciona exclusivamente como información general. En particular, por favor tenga en cuenta que, los contenidos de nuestra plataforma de trading online no son ni solicitud ni una oferta para entrar a realizar transacciones en los mercados financieros. Operar en cualquier mercado financiero implica un nivel de riesgo significativo para su capital.

Todo el material publicado en nuestra plataforma de trading online tiene únicamente fines educativos/informativos y no contiene –y no debe considerarse que contenga– asesoramiento ni recomendaciones financieras, tributarias o de inversión, ni un registro de nuestros precios de trading, ni una oferta ni solicitud de transacción con instrumentos financieros ni promociones financieras no solicitadas.

Cualquier contenido de terceros, así como el contenido preparado por XM, como por ejemplo opiniones, noticias, investigaciones, análisis, precios, otras informaciones o enlaces a sitios de terceros que figuran en este sitio web se proporcionan “tal cual”, como comentarios generales del mercado y no constituyen un asesoramiento en materia de inversión. En la medida en que cualquier contenido se interprete como investigación de inversión, usted debe tener en cuenta y aceptar que dicho contenido no fue concebido ni elaborado de acuerdo con los requisitos legales diseñados para promover la independencia en materia de investigación de inversiones y, por tanto, se considera como una comunicación comercial en virtud de las leyes y regulaciones pertinentes. Por favor, asegúrese de haber leído y comprendido nuestro Aviso sobre investigación de inversión no independiente y advertencia de riesgo en relación con la información anterior, al que se puede acceder aquí.

Advertencia de riesgo: Su capital está en riesgo. Los productos apalancados pueden no ser adecuados para todos. Por favor, tenga en cuenta nuestra Declaración de riesgos.